Joint reconstruction devices market seen reaching $36 billion by 2030

The joint reconstruction devices and equipment market is projected to grow from $28.49 billion in 2026 to $36.02 billion by 2030, according to The Business Research Company. Demand is being driven by rising orthopedic disorders, broader access to surgery, and faster adoption of robotic-assisted and minimally invasive procedures.

Why it matters: - The market is tied to rising demand for hip, knee and shoulder reconstruction as musculoskeletal conditions become more common. - Growth in this segment can affect hospital purchasing, orthopedic surgery capacity and medical device investment over the next several years. - The forecast points to continued expansion in both mature and emerging healthcare markets.

What happened: - The Business Research Company projected the joint reconstruction devices and equipment market will rise from $28.49 billion in 2026 to $36.02 billion in 2030. - The forecast implies a 6.0% compound annual growth rate for the 2026-2030 period. - The market was estimated at $26.98 billion in 2025 and is expected to reach $28.49 billion in 2026, a 5.6% CAGR. - The company published the market outlook on Aug. 13, 2026, from London. - The report is available as the full report. - A free sample is available as a sample report.

The details: - Joint reconstruction devices are implantable medical tools used to replace or restore major joints such as the shoulder, hip or knee. - These devices help resurface or replace damaged bone components to improve mobility and reduce pain. - Growth over the past period was driven by more osteoarthritis cases, wider availability of orthopedic surgeries, advances in implant materials, an aging population and broader access to joint reconstruction procedures. - The report said future growth will be supported by more motion-preserving implants, greater use of robotic-assisted surgery, more outpatient orthopedic procedures, biomaterial innovation and higher investment in orthopedic healthcare infrastructure. - Forecast-period trends include advanced joint replacement implants, minimally invasive reconstruction techniques, patient-specific customization, expanded robotic surgical assistance and improved implant durability and biocompatibility. - In 2025, North America held the largest share of the global market. - Asia-Pacific is expected to post the fastest growth over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - The UK’s Office for Health Improvement & Disparities reported in January 2024 that 18.4% of people aged 16 and older had a long-term musculoskeletal condition in 2023, up from 17.6% in 2022.

Between the lines: - The forecast suggests the market is shifting from basic joint replacement toward more personalized and less invasive procedures. - Robotic assistance and biomaterials are becoming more central to orthopedic device development. - The regional split signals that North America remains the biggest revenue pool while Asia-Pacific could become the fastest-growing demand center.

What's next: - The market is likely to see more investment in robotic systems, outpatient surgery workflows and implant design. - Device makers will probably focus on durability, biocompatibility and customization as competitive differentiators. - Expanding musculoskeletal disease prevalence should keep pressure on healthcare systems to increase reconstruction capacity.

The bottom line: - Joint reconstruction devices and equipment are on a steady growth path, with long-term demand supported by aging populations, rising orthopedic disease and technology upgrades.